HERTFORDSHIRE, England and
PITTSBURGH, May 16, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ,
TASE: MYL) today announced that the company will present at the UBS
Global Healthcare Conference on Monday, May
22, 2017, in New York City.
The presentation is scheduled to begin at 2:30 p.m. ET.
Interested parties can access a live webcast of the presentation
via the investor relations section of Mylan's Web site at
www.mylan.com/investors. An archived version will also be available
following the live presentation and can be accessed at the same
location for a limited time.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of approximately 7,500 marketed products around the
world, including antiretroviral therapies on which approximately
50% of people being treated for HIV/AIDS in the developing world
depend. We market our products in more than 165 countries and
territories. We are one of the world's largest producers of active
pharmaceutical ingredients. Every member of our more than
35,000-strong workforce is dedicated to creating better health for
a better world, one person at a time. Learn more at mylan.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-ubs-global-healthcare-conference-300458819.html
SOURCE Mylan N.V.